6,008 reports of this reaction
4.5% of all LEUPROLIDE ACETATE reports
#5 most reported adverse reaction
DEVICE LEAKAGE is the #5 most commonly reported adverse reaction for LEUPROLIDE ACETATE, manufactured by TOLMAR Inc.. There are 6,008 FDA adverse event reports linking LEUPROLIDE ACETATE to DEVICE LEAKAGE. This represents approximately 4.5% of all 133,873 adverse event reports for this drug.
Patients taking LEUPROLIDE ACETATE who experience device leakage should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE LEAKAGE is moderately reported among LEUPROLIDE ACETATE users, representing a notable but not dominant share of adverse events.
In addition to device leakage, the following adverse reactions have been reported for LEUPROLIDE ACETATE:
The following drugs have also been linked to device leakage in FDA adverse event reports:
DEVICE LEAKAGE has been reported as an adverse event in 6,008 FDA reports for LEUPROLIDE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE LEAKAGE accounts for approximately 4.5% of all adverse event reports for LEUPROLIDE ACETATE, making it a notable side effect.
If you experience device leakage while taking LEUPROLIDE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.